Broadening Scope of Stem Cell Research Propels Global Cell Expansion Market

Transparency Market Research is a top provider of the latest information on market activities. It comprises vast expanses of knowledge on multiple industry verticals, one of which is the global industry of biotechnology. “Cell Expansion Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2023” is the latest offering in this sector.

Request a PDF Brochure:

Cell expansion is the scientific pursuit of creating daughter cells from a single cell. Cell expansion allows a researcher to gain major advantages in therapeutics as well as drug screening, both of which are core research tools. Most of the present uses in the global cell expansion market lie in stem cell research for the purpose of treating patients with leukemia. Other applications of cell expansion lie in the treatment of Alzheimer’s disease, Parkinson’s disease, and other genetic illnesses, all of which are currently under heavy research.

The global cell expansion market can be segmented on the basis of type and application. In terms of types, this market is segmented into plant cells, animal cells, and human cells. Of these, the global cell expansion market is currently dominated by the human cells segment. Human cell expansion studies are useful in generating leads and pathways into the treatment of various genetic issues and cancer.

While animal cell expansion provides little use for modern research scope, plant cell expansion is a segment that is generating increased attention through newfound therapeutic applications.

In terms of applications, the global cell expansion market is segmented into clinical diagnostics, biopharmaceuticals and biotechnology, regenerative medicine, and stem cell research. Of these, the larger chunk of the market is taken up by stem cell research. This segment has garnered a lot of attention for being used as a therapeutic measure against several types of cancers and genetic diseases. As such, the research and development activities in the stem cell segment are tremendous.

For instance, the development of the T-cell, done through Xuri W25 by GE Healthcare, has created solid leads in terms of cancer therapy. The cell expansion research done by GE Healthcare has been the result of large spending by the company in the global cell expansion market.

The segment of regenerative drugs is gaining steam due to its major scope of use in neurological and cardiovascular disease therapeutics.

The global cell expansion market has consistently been dominated by North America, which is followed closely by Europe. Both regions possess an advanced cell expansion market due to a highly developed medical infrastructure and massive incoming support from both government and private sources.

The key players in the global cell expansion market are Thermo Fisher Scientific, Inc., StemCell Technologies, Miltenyi Biotech, Terumo Corporation, Sigma-Aldrich Corporation, Merck Millipore, Corning Incorporated, and Danaher Corporation.

Browse Research Report: